Accessibility Statement

This statement was last updated on April 30th, 2025.

Neuroversis Therapeutics ApS is committed to ensuring digital accessibility for all users, including individuals with disabilities. We strive to continually improve the user experience for everyone and to comply with relevant accessibility standards and guidelines.

Our Commitment

We aim to make the content and features on Neuroversis.com accessible and usable by all visitors, regardless of technology or ability. Our goal is to meet or exceed the Web Content Accessibility Guidelines (WCAG) 2.1, Level AA, established by the World Wide Web Consortium (W3C).

Accessibility Features

To help ensure a positive experience, the Site includes:

Keyboard navigation for key functions
Alternative text for all meaningful images
High-contrast text options
Logical heading structure and semantic HTML
Screen reader compatibility across major browsers
Scalable text and responsive layout for all devices

Known Limitations

Despite our efforts to ensure accessibility, some content may not yet fully comply with accessibility standards. We are actively working to identify and fix these issues.

If you encounter a problem accessing any part of the site or specific content, we want to help.

Feedback & Contact

We welcome your feedback on the accessibility of Neuroversis.com. If you experience any barriers or require assistance, please contact us:

Email: accessibility@neuroversis.com
Phone: +45 29903392
Mail: Neuroversis Therapeutics
Borgmestervangen 31,17,5

2200 Copenhagen

Denmark

Ongoing Improvements

We are committed to continual accessibility enhancements. As we expand our content and services, we regularly test the site for usability and compliance, incorporating feedback from accessibility experts and users alike.